
52.65 Delayed Data As of Jun 29 | ![]() Today’s Change | 46.93 Today|||52-Week Range 58.10 | +5.09% Year-to-Date |
Investors Need Not Be Alarmed by Drug Patent Expirations Jun 28 / GuruFocus News - Paid Partner Content | Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA Jun 25 / MotleyFool.com - Paid Partner Content |
Sanofi (SNY) Wins Nod for Nexviadyme & Xenpozyme in Europe Jun 28 / Zacks.com - Paid Partner Content | Why Sanofi May Be a Frontrunner in Endemic COVID-19 Jun 25 / MotleyFool.com - Paid Partner Content |
Previous close | 52.14 |
Today’s open | 52.63 |
Day’s range | 52.45 - 52.88 |
Volume | 1,813,854 |
Average volume (3 months) | 2,233,940 |
Market cap | $134.0B |
Earnings growth (last year) | -47.56% |
Earnings growth (this year) | -96.15% |
Earnings growth (next 5 years) | +8.75% |
Revenue growth (last year) | +8.63% |
P/E ratio | 20.4 |
Price/Sales | 2.82 |
Price/Book | 1.72 |
Today’s change | Today’s % change | |
---|---|---|
GSKGlaxoSmithKline | -0.01 | -0.02% |
BMYBristol-Myers Squibb | -0.01 | -0.01% |
ZTSZoetis Inc | +3.80 | +2.23% |
---- |
Last reporting date | -- |
EPS forecast (this quarter) | $0.70 |
Annual revenue (last year) | $44.6B |
Annual profit (last year) | $7.4B |
Net profit margin | 16.48% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |